GABA-A receptor antibody encephalitis
Jump to navigation
Jump to search
Etiology
* may or may not be associated malignancy or malignancy may be in remission[1]
Pathology
- inflammatory changes consistent with reactive gliosis
Clinical manifestations
- seizures
- status epilepticus[1]
- seizures may recur after resolution of status epilepticus
- no focal neurological deficits
Laboratory
- CSF analysis
- no pleocytosis
- normal CSF protein
- negative CSF oligoclonal banding
Diagnostic procedures
Radiology
- MRI of brain without gadolinium contrast
- hyperintense lesions on T2 FLAIR sequence in right & left inferior frontal lobes
- new hyperintense lesions on T2 FLAIR sequence may appear after resolution of earlier lesions
* images[1]
Management
- intravenous methylprednisolone & plasmapheresis for 5 days[1]
- maintenance with rituximab[1]
More general terms
Additional terms
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Baqal O, Vanood A, Harahsheh E Magnetic Resonance Imaging Features of GABA-A Receptor Antibody-Mediated Encephalitis. JAMA Neurol. Published online February 6, 2023. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36745432 https://jamanetwork.com/journals/jamaneurology/fullarticle/2801291